Functional Hypothalamic Amenorrhea and a One-Year Fertility Window
A competitive athlete's amenorrhea is genuinely reversible — and genuinely unpredictable in how long that reversal takes, against a fertility window she says she doesn't have to spare.
Lauren F., a 29-year-old woman, has competed in triathlon at a semi-professional level for six years, training roughly 18 hours a week around a full-time job in supply-chain logistics. Her periods stopped fourteen months ago, a change she initially welcomed as one less thing to manage around race season before her PCP's workup connected it to her training volume and a caloric intake that, on review, has been tracking well below what her training load actually demands. She and her husband want to start trying to conceive, and Lauren was explicit in today's visit: she doesn't want to lose a year to an open-ended recovery process at 29, with no fixed sense of when or whether her cycles will return on their own.
Her labs read as classic functional hypothalamic amenorrhea rather than an organic pituitary or ovarian problem — LH 2.1 mIU/mL and FSH 3.4 mIU/mL, both low-normal rather than elevated, estradiol 22 pg/mL, and a pituitary MRI read as normal, ruling out a structural lesion as the driver. That distinction is exactly why this is a genuinely reversible condition and not a fixed gonadotropin deficiency — her hypothalamus has down-regulated GnRH pulsatility in response to relative energy deficiency, a state that, given enough caloric and training-load correction, can spontaneously resolve. How long that correction actually takes for any one patient, though, isn't something the literature can promise on a calendar, and Lauren's own DEXA already shows a lumbar spine Z-score of -1.4 — the age-matched score that applies before menopause — a real, separate consequence of over a year of unreplaced hypoestrogenism that needs its own answer regardless of which fertility path she takes.
Lauren has already made one real change on her own before today's visit — she scaled back her race calendar for next season from four events to one, a decision she describes as harder than anything else being discussed today, since racing has been central to how she's organized her adult life. She has already run the recovery experiment for two months without a readout, and with a Z-score of -1.4 accruing in the background the room has to decide today whether to keep waiting on a hypothalamus that may yet restart, or to start replacing what its silence is costing her.
Consult, fertility timeline stated directly
I'd start gonadotropin therapy now. She's told us directly what her timeline is, and recovery from FHA has no reliable calendar attached to it — some patients resolve in months, some take years, some need a training-load change they aren't able or willing to sustain. Gonadotropins restore ovulation on a schedule she actually controls, which is exactly what a one-year window needs.
If Lauren had said she wasn't in a hurry, I'd be arguing the opposite — recovering the underlying cause first is clearly the better long-term answer when the timeline allows it.
The urgency is real, but pharmacologic ovulation induction doesn't fix the thing actually causing this — relative energy deficiency doesn't resolve because she conceives, and pregnancy on top of an unaddressed energy deficit carries its own risk: impaired maternal bone accrual, a materially harder postpartum recovery, and likely recurrent amenorrhea during lactation. I'd want a structured, time-bounded nutrition and training-load intervention first, with a defined re-assessment point rather than an open-ended wait.
I hear the timeline concern, and that's exactly why I'm proposing a bounded window, not an indefinite one — three to four months of a real intervention, reassessed on a fixed date, still leaves meaningful runway inside her stated year if it doesn't work.
Whichever path you two land on, her bone density can't wait on either timeline. What it specifically can't be is a standard combined oral contraceptive — that would further suppress her hypothalamic-pituitary-ovarian axis and mask the exact recovery the sports medicine physician is trying to detect over the next few months. Transdermal estradiol with cyclic progestin protects bone without adding to axis suppression, and doesn't interfere with either gonadotropin therapy later or spontaneous recovery being monitored for.
Agreed: transdermal estradiol/cyclic progestin started today for bone protection, a structured four-month nutrition and training-load intervention begun immediately with a fixed re-assessment date, and gonadotropin therapy named explicitly as the next step if that window doesn't restore spontaneous ovulation — preserving Lauren's stated one-year timeline either way.
Not fully resolved: whether four months was the right length for the intervention window before defaulting to gonadotropins. The reproductive endocrinologist would have preferred a shorter window given how tight a year actually is once time-to-conception is factored in; the sports medicine physician held that four months was already a compromise from what a genuine recovery attempt would ideally get. Lauren, hearing both, chose the four-month figure herself as the version she could commit to without feeling like she was gambling her timeline away.